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ABSTRACT  
Anogeissus leiocarpus (Combretaceae) is a medicinal plant used by traditional practitioners to treat people living with diabetes mellitus in Togo. 
The objective of this work was to evaluate the hypoglycemic activity of the plant. The hydroalcoholic extract and fractions of A. leiocarpus roots 
was evaluated on hyperglycemic mice by oral glucose tolerance test (OGTT) and on normoglycemic mice. The effect of the total extract and 
fractions was also measured on the adsorption and absorption of glucose respectively in vitro and ex vivo. At 30 minutes after glucose overload, 
the total extract and all fractions (supernatant and pellet) significantly (p< 0.0001) reduced hyperglycemia compared to controls. However, this 
reduction in hyperglycemia was greater in mice treated with the supernatant fraction at 100 mg.kg -1 during 180 minutes (p < 0.01). In our 
conditions, the extract at the 500 mg.kg-1 of the total extract in normoglycemic mice did not significantly decrease (p>0.05) basal blood glucose 
levels compared to controls. In vitro, the extract and fractions of A. leiocarpus adsorbed glucose and inhibited glucose intestinal absorption ex 
vivo. The results of this study support the use of A. leiocarpus as an antidiabetic plant. 
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INTRODUCTION 
Diabetes is a chronic disease, with hallmark pathology of 
hyperglycemia, which is clinically represented by fasting 
blood glucose greater than 7.0 mM and 2 hours glucose level 
greater than 11.1 mM after glucose tolerance test. In 
diabetics, chronic hyperglycemia, source of oxidative stress 
remains a very critical condition because of its nature to 
generate serious complications as retinopathy, nephropathy, 
neuropathy and cardiovascular disease 1. 
Globally, diabetes is the major health issue that has reached 
alarming levels 2. For the management of diabetes, dietary 
changes and oral antihyperglycemic drugs have been 
investigated to stimulate insulin secretion, to decrease 
glucose absorption from the gut, or suppress endogenous 
glucose by increasing glucose peripherical utilization 3. 
Unfortunately, some of them have been failed due to longer- 
term adverse side effects 4. An alternative and perhaps 
underutilized source of new antidiabetic compounds is 
plants because of their lack of major side effects.  
Anogeissus leiocarpus (Guill and Perr) of the family of 
Combretaceae, is a plant which widely spread throughout 
the tropical and subtropical areas. Previous studies on roots, 
stem barks of the plant, revealed antimicrobial, 
antiproliferative, antioxidant and hepatoprotective 
properties 5,6,7. The leaves of A. leiocarpus have been 
scientifically reported to decrease blood glucose effects in 
alloxan-induced diabetic rats 8. Roots of this plant were also 
reported by Kpodar et al to be used traditionally to treat 
people living with diabetes in Togo 9. However, there is still 
no scientific report on its antidiabetic property up to now. 
Consequently, this present investigation was carried out to 
evaluate the hypoglycemic of the roots of A. leiocarpus 
MATERIALS AND METHODS 
Plant material 
Roots of Anogeissus leiocarpus were harvested in Tsévié, Zio 
(TOGO) in the month of July 2018. A voucher specimen was 
identified and was deposited in the herbarium of Laboratory 
of Botany and Plant Ecology under the number TOGO 15483. 
Roots of Anogeissus leiocarpus were cleaned out with water, 
cut into small pieces, dried at the Animal Physiology 
laboratory at 22°C. 
Animals 
ICR mice (25±4 g) and S.D rats (160 ±165 g) were housed in 
Motto et al                                                                                                              Journal of Drug Delivery & Therapeutics. 2020; 10(3):107-113 
ISSN: 2250-1177                                                                                  [108]                                                                                 CODEN (USA): JDDTAO 
standard environmental conditions (temperature 24–25 °C, 
relative humidity and a 12t/12 h light-dark cycle) and fed 
with standard rat diet and water ad libitum. The animals 
were deprived of both food and water during the 
experiment. Principles of laboratory animal care as 
described in institutional guidelines and ethics of Laboratory 
of Physiology/Pharmacology of University of Lome-Togo 
(ref: 001/2012/ CB-FDS-UL) were followed.  
Extraction 
Roots of Anogeissus leiocarpus (400g) were extracted in 
water/ethanol (5:5) for 72 hours. The crude extract was 
filtered on Whatman paper and evaporated in vacuum at 
45°C using a rotary evaporator (Buchi R120). The yield of 
the dry extract was 5.68 %. 
About 30g of hydroethanolic extract obtained was 
suspended in frozen ethanol 75% within 24 hours. 
Supernatant was separated from pellet by centrifugation at 
2500 trs.min-1 and evaporated in vacuum at 45°C using a 
rotary evaporator. Pellet was then concentrated to dryness 
10. 
Effects of total extract of Anogeissus leiocarpus and 
fractions on oral glucose tolerance test 
Hyperglycemia was induced in fasted mice (9 hours) by 
glucose gavage (4g.kg-1 body weight) at a rate of 5 ml.kg-1. 
The animals were divided into 9 groups of 7 rats each. 
Distilled water (control group), total hydro alcoholic extract 
of roots of A. leiocarpus at 125, 250 and 500 mg.kg-1; pellet 
fraction at 50 and 100 mg.kg-1; supernatant fraction (50, 100 
mg.kg-1) and metformin (100 mg.kg-1) were administered by 
gavage 30 minutes before glucose overload.  Blood glucose 
was measured at vein tail by glucometer Accu- Check Active 
(Germany) at 0, 30, 60, 120 and 180 minutes after 
substances administrations 11. 
Effects of total extract of Anogeissus leiocarpus on 
normoglycemic mice 
Three groups of seven fasted mice were used. Group I served 
as a control; group II received total extract of roots of A. 
leiocarpus at a dose of 500 mg.kg-1, and group III received 
metformin at a dose of 100 mg.kg-1. Blood glucose was 
measured as previously. 
Intestinal absorption of total extract and fractions of 
Anogeissus leiocarpus in rat everted gut sac model 
Fiftheen Sprague Dawley rats were fasted for 24 hours with 
access to water. Intestine segments were inverted according 
to the method of Halmilton and Butt, 2013 and weighted 12. 
The incubation medium was Krebs-Henseleit Bicarbonate 
buffer (KHB). The composition of the buffer was (mM/l): 
NaHCO3 25; NaCl 118; KCl 4.7; MgSO4 1.2; CaCl2 1.2; and 
Na2EDTA 9.7 mg/L. After tying, the fragments were filled 
with 1 ml KHB solution (serosal solution), and then placed in 
Elenmeyer's containing 10 ml KHB (mucosal solution). The 
whole mixture was oxygenated and incubated at 37°C with 
continuous stirring 13. 
To study the effect of the plant extracts on the absorption of 
glucose, glucose at varying concentrations (0.4, 0.6, 0.8 and 
1mM/10ml) was added into mucosal compartment fluid just 
before the beginning of the experiment. The total extract 
(5mg.ml-1), the supernatant and pellet fractions (1mg.ml-1) 
were added to the same compartment.  After 60 minutes of 
incubation, the fragments were removed from the gut sac 
bath, and the serosal fluid was drained through a small 
incision into a test tube. Empty sacs were weighed. Glucose 
concentration in the serous and mucous fluids was measured 
using a GOD- PAP kit (method of Trinder). The standard 
range was made by glucose. The amount of glucose in the 
serosal compartment is treated as « release » and was 
calculated and expressed as mM/g tissue wet weight/h. 
Determination of Glucose adsorption capacity of total 
extract and fractions 
This test was performed according to the method of 14 with 
some little modifications. 
Briefly, samples of total extract and fractions (5, 10, 15mg.ml-
1) were added to 10 ml of glucose solution of increasing 
concentrations (5, 10, 20, 50 and 100mM). The mixture was 
stirred well, incubated in a shaker water bath at 37°C for 6 
hours, centrifuged at 4,000×g for 20min. At the end of the 
incubation, glucose concentration was determined by using 
GOD PAP (method of Trinder). 
The percentage of adsorption was calculated using the 
following formula: 
% Adsorption = (G1- G6 / G1) * 100 
G1: glucose concentration of original solution   G6: glucose 
concentration after 6 hours. 
Statistical analysis 
Results were expressed as mean ± standard error of the 
mean (SEM). Statistical analysis was performed by two-way 
analysis of variance (ANOVA) followed by Dunnett’s test to 
evaluate significant differences between groups. The level of 
significance was set at p < 0.05 and statistical analysis were 
carried out using Graph Pad Prism 7.0. 
RESULTS AND DISCUSSION 
Results 
Effects of total extract of Anogeissus leiocarpus and 
fractions on oral glucose tolerance test  
An increase of blood glucose was observed in mice compared 
to controls, after 30 minutes of the administration of glucose. 
Compared to the controls, the total extract of A. leiocarpus at 
the dose of 250 and 500 mg.kg-1, significantly reduced 
hyperglycemia-induced by glucose overload in mice (p < 
0.0001) during one hour. The decrease of hyperglycemia was 
at T30, 18.63% for T.E 250, 30.89 % for T.E 500; and 
respectively 23.18 %, 32.58 % at T60 compared to controls 
(figure 1A). This significant reduction of blood glucose level 
was confirmed by the area under the curve of the glucose 
tolerance which measured the total amount of available 
glucose in the blood compared to controls (figure 1B).  
During 30 minutes, the pellet at 50 and 100 mg.kg-1 caused a 
significant decrease (p < 0.0001) of the amount of glucose in 
blood respectively 11.79 % and 27.64 % compared to 
controls. 
At the dose of 50 mg.kg-1 of the supernatant, the reduction of 
glycemia occurred at T30, T60 (p< 0.0001) and T120 (p< 
0.05); respectively 26.82%, 19.09 % and 22.54% of 
reduction. 
Supernatant fraction (100 mg.kg-1) significantly decreased 
significantly (p < 0.0001) the blood glucose level. The 
percentage of reduction was at T30 (51.22%), T60 (50.14%), 
T120 (43.51%) and T180 with 39.58 % at p< 0.01 compared 
to controls (Figure 2A).  
This significant reduction of blood glucose level was 
confirmed by the decrease of the area under the curve of the 
glucose tolerance (Figure 2B).  
Motto et al                                                                                                              Journal of Drug Delivery & Therapeutics. 2020; 10(3):107-113 
ISSN: 2250-1177                                                                                  [109]                                                                                 CODEN (USA): JDDTAO 
G
ly
c
e
m
ia
 (
m
g
.d
l-
1
)
0 5 0 1 0 0 1 5 0 2 0 0
0
1 0 0
2 0 0
3 0 0
C o n tro l
T .E  1 2 5
T .E  2 5 0
T .E  5 0 0
M e t 1 0 0
****
****
****
****
****
**** ****
T im e  (m in )
 
Figure 1A: Effect of total extract on hyperglycemia 
 
Hyperglycemia was induced by administrating orally 4 g.kg-1 
of glucose to fasted mice. Control: received distillated water. 
T.E 125, T.E 250 and T.E 500: treated respectively with 125, 
250 and 500 mg.kg-1of the total extract; Met: treated with 
metformin at 100 mg.kg-1, used as reference drug. Results 
were expressed as mean ± SEM. ****p<0.0001; ***p <0.001; 
**p<0.01; *p<0.05: compared to the control. N=7 
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Figure 1B: Area under the curve of blood glucose 
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Figure 2A: Effect of fractions on hyperglycemia 
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Hyperglycemia was induced by administrating orally 4 g.kg-1 
of glucose to fasted mice. Control: received distillated water. 
Pel.50, Pel.100: respectively treated with 50 and 100 mg.kg-1 
of the pellet supernatant; Sup.50, Sup.100: treated 
respectively with 50 and 100 mg.kg-1 of the supernatant; Met: 
treated with metformin at 100 mg.kg-1, used as reference 
drug. Results were expressed as mean ± SEM. ****p<0.0001; 
***p <0.001; **p<0.01; *p<0.05: compared to the control. N=7
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Figure 2B: Area under the curve of blood glucose 
 
Effects of total extract of Anogeissus leiocarpus on 
normoglycemic mice 
At the dose of 500 mg.kg-1, hydroalcoholic extract of A. 
leiocarpus has not decreased significantly (p> 0.05) basal 
glucose level in mice compared to controls. The same effect 
was noticed with Metformin (Figure 2A). Compared to 
controls, no significant reduction of basal blood glucose level 
was indicated by the area under the curve (Figure 2B). 
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Figure 3A: effect of hydroalcoholic total extract on normoglycemic mice 
 
 
After measuring basal blood glucose level, distilled water and 
the extract were administrated to 9 hours fasted mice. 
Control: received distillated water. T.E 500: treated with 500 
mg.kg-1 of the extract; Met: treated with metformin at 100 
mg.kg-1. Results were expressed as mean ± SEM. N=7. 
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Figure 3B: Area under the curve of basal blood glucose 
 
Effect of the total extract and fractions of Anogeissus 
leiocarpus on intestinal glucose absorption 
In the presence of 0.6 mM of glucose, there was a significant 
reduction of released glucose in the reverse intestine treated 
with total extract (p<0.01), pellet and supernatant fraction 
(p<0.001). This diminution was more pronounced (p<0.001) 
in reverse intestine treated with supernatant fraction 
compared to controls in the presence of 1mM of glucose 
(Table 1). 
 
Table 1:  Effect of hydroalcoholic total extract and fractions of Anogeissus leiocarpus on the release of the varying concentrations 
of glucose by everted gut sacs 
   Released Glucose (mM.g-1 tissue wet weight.h-1) 
Glucose concentration 
(mM/10ml) 
Control Total Extract 
(5mg.ml-1) 
   Pellet  (1mg.ml-1) Supernatant 
(1mg.ml-1) 
 
0.4 
 
0.23 ± 0.01 
 
0.24 ± 0.02 
 
0.41 ± 0.04 
 
0.36 ± 0.08 
0.6 1.38 ± 0.01 0.92 ± 0.14** 0.69 ± 0.03*** 0.53 ± 0.10*** 
0.8 1.52 ± 0.01 1.08 ± 0.13* 1.06 ± 0.11** 1.05 ± 0.02** 
1 1.72 ± 0.02 1.39 ± 0.12 1.35 ± 0.18* 1.14 ± 0.18*** 
The fragment of the everted gut sacs were incubated in Kerbs-Henseleit Buffer at 37°C. Values are expressed as mean ± SEM of 
three experiments. *p < 0.05; **p < 0.01; ***p < 0.001 vs control.  
 
Adsorption capacity of total extract and fractions of 
Anogeissus leiocarpus 
The total extract and fractions of A. leiocarpus adsorbed 
glucose in vitro. The percentage of glucose adsorption 
decreased as the glucose concentration increased. It varied 
from 27 to 79% and from 47 to 74% when the glucose 
concentrations were respectively 50 and 100mM. At the 
glucose concentrations (50 and 100 mM), there was an 
increase in the percentage of adsorption when the 
concentration of extract or fractions increased (Figures 4D 
and 4E). At G=5 mM, it should be noted that the total extract 
or supernatant at 5mg.ml-1 adsorbed 100% of the glucose 
(Figure 4A). The pellet adsorbed less glucose than the total 
extract and supernatant (Figure 4). 
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Figure 4: glucose binding capacity of hydroalcoholic total extract and fractions at different concentrations of glucose 
(A, B, C, D and E). 
Samples of total extract and fractions (5, 10, 15mg.ml-1) were 
added to 10 ml of glucose solution of increasing 
concentrations (5, 10, 20, 50 and 100mM). Each value 
represents mean + SEM, N=3. 
DISCUSSION 
Our study was undertaken in order to evaluate the 
hypoglycemic property of the hydroalcoholic extract and root 
fractions of A. leiocarpus. 
An increase of the blood glucose level occurred when 4 g.kg-1 
glucose was administrated orally to mice, with a peak at 30 
minutes which returned to the basal glucose level after 120 
minutes. This is due to the fact that in general circulation, 
glucose first raises blood glucose levels before being used for 
the body's needs or stored under the direct action of insulin 
15. 
The hypoglycemic activity of the total extract, pellet and 
supernatant fractions of A. leiocarpus roots was evaluated in 
normal mice with orally induced hyperglycemia. At 30 
minutes after glucose overload, the total extract and all 
fractions (supernatant and pellet) significantly reduced 
hyperglycemia dose - dependent manner compared to 
controls. However, the reduction of hyperglycemia was more 
pronounced in mice treated with the supernatant fraction at 
100 mg.kg-1. This was confirmed by the aera under the curve. 
The same effect was noticed with the group treated with 
Metformin. 
It is well established that metformin has a multifactorial 
mode of action, by improving insulin sensitivity (increasing 
peripheral glucose utilization) and decreasing hepatic 
glucose production. It also reduces the gastrointestinal 
absorption of glucose in people living with diabete type 2 16. 
In our conditions, the extract at the 500 mg.kg-1 of the total 
extract in normoglycemic mice did not significantly decrease 
basal blood glucose levels compared to controls. As 
metformin, the hydroalcoholic extract of the roots of A 
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leiocarpus would possess an antihyperglycemic activity, 
suggesting an extra-pancreatic mechanism of action. On the 
order side, on alloxan inducing diabetic rats, Onoja et al 
revealed the hypoglycemic activity of the ethanolic extract of 
leaves of A. leiocarpus [8]. The extract may increase the use of 
glucose by peripheral tissues, decrease intestinal absorption 
of glucose or store it in the form of glycogen as metformin 17.  
Severe postprandial hyperglycaemia is avoided if intestinal 
glucose absorption is inhibited.  
The inverted intestine test was adopted in order to reveal the 
effect of the plant on intestinal absorption of glucose. Glucose 
enters the epithelial cells following secondary active Na+-
coupled transport via sodium-glucose co-transporters 
(SGLT1 and 2). It is then absorbed through the basolateral 
membrane into the interstitial fluid by facilitated diffusion 
(GLUT2) and then diffused into blood 18. Ex vivo, the 
significant reduction of released glucose in the reverse 
intestine observed, showed that the total extract and 
supernatant fraction reduced the glucose’s absorption. This 
was more potent with supernatant fraction than the total 
extract. The extract would regulate the glucose uptake by 
inhibiting its absorption. 
To elucidate the mechanism by which total extract and 
supernatant fraction inhibited the intestinal absorption of 
glucose, in vitro glucose adsorption test was therefore carried 
out. 
After 6 hours of incubation, we noticed that the total extract 
and the fractions adsorbed glucose by binding it in vitro. 
Nevertheless, the supernatant fraction bound more glucose 
than the total extract. The results indicated that the 
adsorption capacities of the total extract and fractions were 
directly proportional to the molar concentration of glucose 
and higher amount of glucose was bound with the increasing 
of glucose concentration. This proportionality was also found 
by Bhutkar et al who evaluated the adsorption capacity of 
plants as B. aristate and M. pruriens 19. Thereby, the extract 
would to slow down the intestinal absorption of glucose by 
binding glucose, consequently reduces the postprandial 
hyperglycemia. 
This increasing capacity to bind glucose may be due to the 
phytoconstituent present in the extract. 
CONCLUSION 
The study has revealed the antihyperglycemic activity of the 
total hydroalcoolic extract, fractions of A. leiocarpus roots 
and some of its extra pancreatic activity by binding glucose 
and inhibited the absorption of glucose in the intestine. This 
justifies the traditional use of Anogeissus leiocarpus in the 
treatment of diabetes type 2. For the full elucidation of the 
mechanism of action of the plant, further studies are needed 
to be carried out. 
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